Dashboard
Manage Tickers

HZNPHorizon Therapeutics Public...

Nasdaq horizontherapeutics.com


$ 116.30 $ 0.05 (0.04 %)    

Thursday, 05-Oct-2023 15:59:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 116.3
$ 116.36
$ 116.32 x 100
$ 0.00 x 0
$ 116.26 - $ 116.36
$ 60.03 - $ 116.38
28,881,250
na
27.21B
$ 0.66
$ 62.12
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2023 06-30-2023 10-Q
2 05-03-2023 03-31-2023 10-Q
3 03-01-2023 12-31-2022 10-K
4 11-02-2022 09-30-2022 10-Q
5 08-03-2022 06-30-2022 10-Q
6 05-04-2022 03-31-2022 10-Q
7 03-01-2022 12-31-2021 10-K
8 11-03-2021 09-30-2021 10-Q
9 08-04-2021 06-30-2021 10-Q
10 05-05-2021 03-31-2021 10-Q
11 02-24-2021 12-31-2020 10-K
12 11-02-2020 09-30-2020 10-Q
13 08-05-2020 06-30-2020 10-Q
14 05-06-2020 03-31-2020 10-Q
15 02-26-2020 12-31-2019 10-K
16 11-06-2019 09-30-2019 10-Q
17 08-07-2019 06-30-2019 10-Q
18 05-08-2019 03-31-2019 10-Q
19 02-27-2019 12-31-2018 10-K
20 02-27-2019 12-31-2018 10-K
21 11-07-2018 09-30-2018 10-Q
22 08-08-2018 06-30-2018 10-Q
23 05-09-2018 03-31-2018 10-Q
24 02-28-2018 12-31-2017 10-K
25 11-06-2017 09-30-2017 10-Q
26 08-07-2017 06-30-2017 10-Q
27 05-08-2017 03-31-2017 10-Q
28 02-27-2017 12-31-2016 10-K
29 11-07-2016 09-30-2016 10-Q
30 08-08-2016 06-30-2016 10-Q
31 05-09-2016 03-31-2016 10-Q
32 02-29-2016 12-31-2015 10-K
33 11-06-2015 09-30-2015 10-Q
34 08-07-2015 06-30-2015 10-Q
35 05-08-2015 03-31-2015 10-Q
36 02-27-2015 12-31-2014 10-K
37 11-06-2014 09-30-2014 10-Q
38 08-07-2014 06-30-2014 10-Q
39 05-09-2014 03-31-2014 10-Q
40 03-13-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

peering-into-horizon-therapeuticss-recent-short-interest
Peering Into Horizon Therapeutics's Recent...
10/05/2023 20:15:18

Core News & Articles
Horizon Therapeutics Announced Acquisition...
10/05/2023 11:39:38

-8-K As previously disclosed, on December 11, 2022, Horizon Therapeutics plc (“Horizon”), Amgen Inc. (“Amgen”) and Pillartree ...

heres-how-much-100-invested-in-horizon-therapeutics-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Horizon T...
10/04/2023 16:30:27

horizon-therapeutics-plc-announces-new-uplizna-data-in-neuromyelitis-optica-spectrum-disorder-to-be-presented-at-ectrims-2023
Horizon Therapeutics Plc Announces New UPL...
10/02/2023 12:14:12

-- Presentations will feature data from the pivotal Phase 3 study of UPLIZNA, including new biomarker analyses --Horizon Therap...

horizon-therapeutics-plc-announces-new-analysis-highlights-importance-of-adhering-to-uninterrupted-full-course-of-treatment-with-tepezza-to-support-thyroid-eye-disease-patient-outcomes
Horizon Therapeutics Plc Announces New Ana...
09/29/2023 14:03:18

-- Additional data presented at ATA 2023 include a subgroup analysis from the TEPEZZA Phase 4 clinical trial and insights on th...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/28/2023 17:35:26

how-is-the-market-feeling-about-horizon-therapeutics
How Is The Market Feeling About Horizon Th...
09/18/2023 14:15:24

q32-bio-and-horizon-therapeutics-have-dosed-the-first-patient-in-phase-2-study-of-bempikibart-in-adult-patients-with-severe-alopecia-areata
Q32 Bio And Horizon Therapeutics Have Dose...
09/13/2023 12:08:19

 Q32 Bio and Horizon are collaborating to develop bempikibart, a fully human anti-IL-7Rα antibody that re-regulates adaptive im...

q32-bio-and-horizon-therapeutics-announce-dosing-of-first-patient-in-phase-2-trial-of-bempikibart-for-severe-alopecia-areata
Q32 Bio And Horizon Therapeutics Announce ...
09/13/2023 12:05:57

-- Alopecia areata is the second autoimmune indication being evaluated for bempikibart --

these-3-health-care-stocks-with-over-3-dividend-yields-are-recommended-by-wall-streets-most-accurate-analysts
These 3 Health Care Stocks With Over 3% Di...
09/13/2023 11:35:21

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

1000-invested-in-horizon-therapeutics-10-years-ago-would-be-worth-this-much-today
$1000 Invested In Horizon Therapeutics 10 ...
09/12/2023 20:30:19

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/11/2023 17:35:22

amgens-horizon-acquisition-offers-multiple-advantages-tax-breaks-shield-from-drug-pricing-negotiations
Amgen's Horizon Acquisition Offers Multipl...
09/05/2023 17:52:20

On Friday, the U.S.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
09/05/2023 17:35:26

horizon-therapeutics-announces-date-of-irish-court-hearing-to-sanction-scheme-of-arrangement-date-set-for-october-5-2023
Horizon Therapeutics Announces Date of Iri...
09/05/2023 13:06:18

heres-how-much-1000-invested-in-horizon-therapeutics-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Horizon ...
09/04/2023 18:00:25

this-is-what-whales-are-betting-on-horizon-therapeutics
This Is What Whales Are Betting On Horizon...
09/01/2023 20:03:51

amgen-horizon-therapeutics-28b-acquisition-federal-trade-commission-gives-green-signal
Amgen-Horizon Therapeutics $28B Acquisitio...
09/01/2023 14:47:38

The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billi...

Core News & Articles
Amgen And Horizon Therapeutics Resolve FTC...
09/01/2023 13:10:19

-Reuters

peering-into-horizon-therapeuticss-recent-short-interest
Peering Into Horizon Therapeutics's Recent...
08/31/2023 16:15:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION